Structure-Based and Multiple Potential Three-Dimensional Quantitative Structure-Activity Relationship (SB-MP-3D-QSAR) for Inhibitor Design
暂无分享,去创建一个
Jing Gao | Qishi Du | Ri-Bo Huang | Yu-Tuo Wei | Li-Qin Du | Shu-Qing Wang | Shu-Qing Wang | Yu-Tuo Wei | Li-Qin Du | Q. Du | R. Huang | Jing Gao
[1] K. Goa,et al. Zanamivir , 1999, Drugs.
[2] T. Creamer,et al. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. , 1996, Biochemistry.
[3] Stephen Hanessian,et al. A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors. , 2006, Journal of medicinal chemistry.
[4] W G Laver,et al. A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity. , 1998, Bioorganic & medicinal chemistry letters.
[5] E Uriarte,et al. Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.
[6] M. Wang,et al. Low-frequency Fourier spectrum for predicting membrane protein types. , 2005, Biochemical and biophysical research communications.
[7] R K Robins,et al. Analysis of the in vitro antitumor activity of novel purine-6-sulfenamide, -sulfinamide, and -sulfonamide nucleosides and certain related compounds using a computer-aided receptor modeling procedure. , 1991, Journal of medicinal chemistry.
[8] Huanxiang Liu,et al. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase. , 2010, Molecular pharmaceutics.
[9] K C Chou,et al. An analysis of protein folding type prediction by seed-propagated sampling and jackknife test , 1995, Journal of protein chemistry.
[10] R. D. Iii Cramer,et al. Comparative Molecular Field Analysis (CoMFA). Part 1. Effect of Shape on Binding of Steroids to Carrier Proteins. , 1988 .
[11] A. Benítez-Páez,et al. Dissection of Functional Residues in Receptor Activity-Modifying Proteins Through Phylogenetic and Statistical Analyses , 2008, Evolutionary bioinformatics online.
[12] W C Guida,et al. The significance of chirality in drug design and development. , 2011, Current topics in medicinal chemistry.
[13] W G Laver,et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.
[14] E. Oldfield,et al. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. , 2004, Journal of medicinal chemistry.
[15] Qishi Du,et al. Theoretical Derivation of Heuristic Molecular Lipophilicity Potential: A Quantum Chemical Description for Molecular Solvation , 2005, J. Chem. Inf. Model..
[16] P. Cintas. Tracing the origins and evolution of chirality and handedness in chemical language. , 2007, Angewandte Chemie.
[17] Kuo-Chen Chou,et al. Peptide reagent design based on physical and chemical properties of amino acid residues , 2007, J. Comput. Chem..
[18] Yongbo Hu,et al. Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy , 2009, J. Chem. Inf. Model..
[19] Ajay N. Jain,et al. Parameter estimation for scoring protein-ligand interactions using negative training data. , 2006, Journal of medicinal chemistry.
[20] Giuseppe Bifulco,et al. Determination of the relative stereochemistry of flexible organic compounds by Ab initio methods: conformational analysis and Boltzmann-averaged GIAO 13C NMR chemical shifts. , 2002, Chemistry.
[21] Brian J. Smith,et al. Analysis of inhibitor binding in influenza virus neuraminidase , 2001, Protein science : a publication of the Protein Society.
[22] Setsuzo Tejima,et al. THE ROTATORY DISPERSION AND STEREOCHEMISTRY OF ORGANIC COMPOUNDS. VII. MONOSULFIDES AND DISULFIDES DERIVED FROM GLUCOSE AND GLUCOSAMINE. , 1965, Bulletin of the Chemical Society of Japan.
[23] S. White,et al. Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.
[24] René Thomsen,et al. MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.
[25] J. Shim. Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery , 2010 .
[26] Xiaowu Chen,et al. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. , 2000, Current medicinal chemistry.
[27] G. Air,et al. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. , 1999, Journal of medicinal chemistry.
[28] Dapeng Li,et al. Heuristic molecular lipophilicity potential (HMLP): Lipophilicity and hydrophilicity of amino acid side chains , 2006, J. Comput. Chem..
[29] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[30] Q Gu,et al. Prediction of G-protein-coupled receptor classes in low homology using Chou's pseudo amino acid composition with approximate entropy and hydrophobicity patterns. , 2010, Protein and peptide letters.
[31] E. Akı-Şener,et al. 3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA , 2006, SAR and QSAR in environmental research.
[32] Lukasz A. Kurgan,et al. Prediction of protein folding rates from primary sequences using hybrid sequence representation , 2009, J. Comput. Chem..
[33] Predrag Radivojac,et al. Computational methods for identification of functional residues in protein structures. , 2011, Current protein & peptide science.
[34] V. Papadopoulos,et al. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. , 2006, Bioorganic & medicinal chemistry letters.
[35] Kuo-Chen Chou,et al. Multiple field three dimensional quantitative structure–activity relationship (MF‐3D‐QSAR) , 2008, J. Comput. Chem..
[36] Qishi Du,et al. Empirical formulation and parameterization of cation–π interactions for protein modeling , 2012, J. Comput. Chem..
[37] Stephen H. White,et al. Experimentally determined hydrophobicity scale for proteins at membrane interfaces , 1996, Nature Structural Biology.
[38] Kuo-Chen Chou,et al. Heuristic molecular lipophilicity potential (HMLP): A 2D‐QSAR study to LADH of molecular family pyrazole and derivatives , 2005, J. Comput. Chem..
[39] K. Chou,et al. Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design. , 2008, Current protein & peptide science.
[40] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[41] V. Gineitytė. A simple topological factor determining the allowance of pericyclic reactions , 2008 .
[42] Kuo-Chen Chou,et al. Fragment‐based quantitative structure–activity relationship (FB‐QSAR) for fragment‐based drug design , 2009, J. Comput. Chem..
[43] W G Laver,et al. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. , 1998, Journal of medicinal chemistry.
[44] A. Norman,et al. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. , 2004, Journal of medicinal chemistry.
[45] Xiaoqin Zou,et al. Construction and Test of Ligand Decoy Sets Using MDock: Community Structure-Activity Resource Benchmarks for Binding Mode Prediction , 2011, J. Chem. Inf. Model..
[46] E. Oldfield,et al. Quantitative Structure-Activity Relationships for γδ T Cell Activation by Bisphosphonates , 2004 .
[47] R. Stevens,et al. Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Antiinfluenza Activity. , 1997 .
[48] Q. Du,et al. Energies and physicochemical properties of cation-π interactions in biological structures. , 2012, Journal of molecular graphics & modelling.
[49] Robert D. Clark,et al. SYBYL Line Notation (SLN): A Single Notation To Represent Chemical Structures, Queries, Reactions, and Virtual Libraries , 2008, J. Chem. Inf. Model..
[50] Uko Maran,et al. Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase , 2011, J. Chem. Inf. Model..
[51] Gerhard Klebe,et al. Development of new hydrogen-bond descriptors and their application to comparative molecular field analyses. , 2002, Journal of medicinal chemistry.
[52] M. Lawrence,et al. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase , 1993, Journal of virology.
[53] R. Cramer,et al. Recent advances in comparative molecular field analysis (CoMFA). , 1989, Progress in clinical and biological research.
[54] Kuo-Chen Chou,et al. Prediction of G-protein-coupled receptor classes. , 2005, Journal of proteome research.